Targeting Protein-Protein Interactions in the Proteasome Super-Assemblies

Area of Science:

• Molecular Biology
• Biochemistry
• Drug Discovery

Background:

• Protein-protein interactions (PPI) are fundamental to cellular functions, including regulation, structural integrity, and signaling.
• The proteasome, a critical cellular machine for protein degradation, heavily relies on PPI for its assembly and function.
• The proteasome is a validated drug target for cancer and inflammatory diseases.

Purpose of the Study:

• To review the potential of targeting PPI within the proteasome for novel therapeutic interventions.
• To explore the opportunities and challenges associated with developing drugs that modulate proteasome subunit interactions.
• To highlight the largely untapped resource of proteasome PPI for drug design.

Main Methods:

• Literature review of existing research on proteasome structure and function.
• Analysis of the role of PPI in proteasome assembly and activity.
• Discussion of current therapeutic strategies targeting the proteasome and their limitations.

Main Results:

• Proteasome function is critically dependent on intricate interactions between its multiple subunits and modules.
• The interface regions between proteasome components represent a rich platform for drug development.
• Current proteasome-targeting drugs are limited to classical competitive inhibitors of catalytic centers.

Conclusions:

• Targeting proteasome PPI presents a promising avenue for developing diverse therapeutic agents.
• This strategy moves beyond conventional inhibition, offering novel mechanisms of action.
• Further research into proteasome PPI interfaces is crucial for unlocking their full therapeutic potential.